About: MAM-2201

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in synthetic cannabis smoking blends. Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by "research chemical" suppliers specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries.

Property Value
dbo:abstract
  • MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in synthetic cannabis smoking blends. Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by "research chemical" suppliers specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries. A study of MAM-2201 in rats showed that it causes neurofunctional disruptions. (en)
dbo:casNumber
  • 1354631-24-5
dbo:fdaUniiCode
  • P4KP9PRG29
dbo:pubchem
  • 66570720
dbo:thumbnail
dbo:wikiPageID
  • 36392139 (xsd:integer)
dbo:wikiPageLength
  • 5836 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1091624626 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 25 (xsd:integer)
dbp:casNumber
  • 1354631 (xsd:integer)
dbp:chemspiderid
  • 28289977 (xsd:integer)
dbp:f
  • 1 (xsd:integer)
dbp:h
  • 24 (xsd:integer)
dbp:iupacName
  • methanone (en)
dbp:legalCa
  • Schedule II (en)
dbp:legalDe
  • Anlage II (en)
dbp:legalNz
  • Temporary Class (en)
dbp:legalUk
  • Class B (en)
dbp:legalUs
  • Schedule I (en)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 1 (xsd:integer)
dbp:pubchem
  • 66570720 (xsd:integer)
dbp:smiles
  • FCCCCCnc2ccccc2c4Cc3cccc1ccccc13 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • IGBHZHCGWLHBAE-UHFFFAOYSA-N (en)
dbp:unii
  • P4KP9PRG29 (en)
dbp:width
  • 150 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in synthetic cannabis smoking blends. Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by "research chemical" suppliers specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries. (en)
rdfs:label
  • MAM-2201 (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License